Genelux will meet investors at BTIG Biotechnology Conference 2026 to outline its immuno-oncology strategy. CEO Thomas Zindrick and CFO Matt Pulisic are set to d

BWB News TV • 2026-07-24 13:11 UTC • By Billy Odell Tucker-Robinson

Genelux will meet investors at BTIG Biotechnology Conference 2026 to outline its immuno-oncology strategy. CEO Thomas Zindrick and CFO Matt Pulisic are set to discuss pipeline progress, after recent Olvi-Vec ovarian cancer data and NOCC National talks.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly